3 December 2019 in Journal of Arrhythmia
EAEric Noel Gonzales Aceves
Eric Noel Gonzales Aceves
CICarlos Erick Cardona Ibarra
Carlos Erick Cardona Ibarra
+7
Purpose: Catheter ablation is an effective therapy for atrial fibrillation (AF). However, risks remain, and improved efficacy is desired. Stereotactic body radiotherapy (SBRT) is a well‐established therapy used to noninvasively treat malignancies and functional disorders with precision. We evaluated the feasibility of stereotactic radioablation for treating paroxysmal AF.Methods: Two patients with drug‐refractory paroxysmal AF underwent pulmonary vein isolation with SBRT. After placement of a percutaneous active fixation temporary pacing lead tracking fiducial, computed tomography (CT) angiography was performed to define left atrial anatomy. A tailored planning treatment volume was created to deliver contiguous linear ablations to isolate the pulmonary veins and posterior wall. Patients were treated on an outpatient basis in the radioablation suite. Clinical follow‐up was performed through at least 24 months after therapy.Results: Both patients successfully underwent SBRT planning and treatment without significant early or long‐term side effects up to 48 months of follow‐up. One patient had AF recurrence after 6 months free of arrhythmia, while the second patient remains free of AF after 24 months with fibrosis detected on MRI scan consistent with the ablation lesion set. An incidentally noted small pericardial effusion occurred in one patient.Conclusion: Stereotactic radioablation may be feasible for the treatment of drug‐refractory AF. Further evaluation is warranted.
1 June 2019 in JACC: Cardiovascular Interventions
1 May 2018 in EP Europace
Remote magnetic navigation (RMN) is a safe and effective means of performing ventricular tachycardia (VT) ablation. It may have advantages over manual catheter ablation due to ease of manoeuvrability and catheter stability. We sought to compare the safety and efficacy of RMN vs. manual VT ablation. Retrospective study of procedural outcomes of 139 consecutive VT ablation procedures (69 RMN, 70 manual ablation) in 113 patients between 2009 and 2015 was performed. Remote magnetic navigation was associated with overall higher acute procedural success (80% vs. 60%, P = 0.01), with a trend to fewer major complications (3% vs. 9% P = 0.09). Seventy-nine patients were followed up for a median of 17.0 [interquartile range (IQR) 3.0–41.0] months for the RMN group and 15.5 (IQR 6.5–30.0) months for manual ablation group. In the ischaemic cardiomyopathy subgroup, RMN was associated with longer survival from the composite endpoint of VT recurrence leading to defibrillator shock, re-hospitalization or repeat catheter ablation and all-cause mortality; single-procedure adjusted hazard ratio (HR) 0.240 (95% CI 0.070–0.821) P = 0.023, multi-procedure HR 0.170 (95% CI 0.046–0.632) P = 0.002. In patients with implanted defibrillators, multi-procedure VT-free survival was superior with RMN, HR 0.199 (95% CI 0.060–0.657) P = 0.003. Remote magnetic navigation may improve clinical outcomes after catheter ablation of VT in patients with ischaemic cardiomyopathy. Further prospective clinical studies are required to confirm these findings.
25 August 2015 in Journal of Interventional Cardiac Electrophysiology
1 April 2021 in JACC: Clinical Electrophysiology
28 May 2015 in Journal of Cardiovascular Electrophysiology